Reuters
False Claims Act Liability: When Do Claims for Health Care Reimbursement 'Result From' Anti-Kickback Statute Violations?
September 25, 2025
The Department of Justice and Department of Health and Human Services recently renewed their False Claims Act (FCA) Working Group, reinforcing scrutiny of health care and life sciences companies, with a focus on Anti-Kickback Statute (AKS) violations. A circuit split has developed over whether FCA liability requires strict “but-for” causation between AKS violations and reimbursement claims, or only a looser “link.” Most circuits now favor the more stringent “but-for” standard, while the 3rd Circuit continues to apply the link test. As courts move toward the stricter view, DOJ and relators are increasingly relying on false certification theories to pursue FCA claims tied to AKS violations.
Contacts
Capabilities
Suggested News & Insights
First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Sidley Secures Landmark FCA Defense Victory for Novo NordiskNovember 18, 2025U.S. DOJ Announces Renewal of FCA Working GroupNovember - December 2025U.S. Treasury Launches Departmentwide Review of Preference-Based Contracting ProgramsNovember 11, 2025Torrey Cope Featured on Fierce Biotech's The Top Line Podcast Episode, "Unpacking the FDA Transparency Push on CRLs"October 17, 2025DOJ Announces Renewal of FCA Working GroupOctober 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


